Brazil Multiomics Market Size & Outlook, 2023-2030
Brazil multiomics market, 2018-2030 (US$M)
Related Markets
Brazil multiomics market highlights
- The Brazil multiomics market generated a revenue of USD 45.8 million in 2023 and is expected to reach USD 108.9 million by 2030.
- The Brazil market is expected to grow at a CAGR of 13.2% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Multiomics market data book summary
| Market revenue in 2023 | USD 45.8 million |
| Market revenue in 2030 | USD 108.9 million |
| Growth rate | 13.2% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.9% of the global multiomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil multiomics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 108.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multiomics Market Scope
Multiomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil multiomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 64.63% in 2023. Horizon Databook has segmented the Brazil multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil has a notable reputation for the frequent occurrence of emerging infectious diseases, such as Zika, dengue, and chikungunya. For instance, Brazil has reported over 100,000 cases of the Zika virus since the conclusion of the period of Public Health Emergency of International Concern in 2016.
Moreover, in June 2023, the Brazilian Ministry of Health (MoH) notified the WHO about a fatal human case of a sporadic variant virus infection. A test conducted by the Brazil National Influenza Center identified that the virus is genetically related to swine influenza viruses detected previously in swine in Brazil.
Thus, due to the growing incidence of infectious diseases, Brazil has witnessed significant expansion in multiomics research. On the other hand, with rise in the number of infectious disease cases and the pivotal role of multiomics in offering solutions, numerous companies are devising strategies to enhance their genomics-based endeavors in the region.
Reasons to subscribe to Brazil multiomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil multiomics market databook
-
Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil multiomics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil multiomics market size, by product & service, 2018-2030 (US$M)
Brazil Multiomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
